Literature DB >> 33574218

Reduced CXCL4/PF4 expression as a driver of increased human hematopoietic stem and progenitor cell proliferation in polycythemia vera.

Markus G Manz1, Ruedi Aebersold2,3, Alexandre P A Theocharides1, Fabienne Meier-Abt4,5, Witold E Wolski6,7, Ge Tan6, Sandra Kummer1, Sabine Amon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33574218      PMCID： PMC7878875          DOI： 10.1038/s41408-021-00423-5

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  15 in total

Review 1.  TGF-β signaling in the control of hematopoietic stem cells.

Authors:  Ulrika Blank; Stefan Karlsson
Journal:  Blood       Date:  2015-04-01       Impact factor: 22.113

Review 2.  Myeloproliferative neoplasm stem cells.

Authors:  Adam J Mead; Ann Mullally
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

3.  Consequences of GATA-1 deficiency in megakaryocytes and platelets.

Authors:  P Vyas; K Ault; C W Jackson; S H Orkin; R A Shivdasani
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

4.  Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.

Authors:  K Aneja; G Jalagadugula; G Mao; A Singh; A K Rao
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

5.  Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer.

Authors:  Shaorong Deng; Qing Deng; Yingjie Zhang; Hao Ye; Xiaolan Yu; Yang Zhang; Grace Yq Han; Ping Luo; Mingyuan Wu; Yan Yu; Wei Han
Journal:  Cancer Lett       Date:  2018-11-24       Impact factor: 8.679

6.  Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.

Authors:  Ayalew Tefferi; Tiziano Barbui
Journal:  Am J Hematol       Date:  2018-11-09       Impact factor: 10.047

Review 7.  Molecular regulation of stem cell quiescence.

Authors:  Tom H Cheung; Thomas A Rando
Journal:  Nat Rev Mol Cell Biol       Date:  2013-06       Impact factor: 94.444

8.  Multiple ETS family proteins regulate PF4 gene expression by binding to the same ETS binding site.

Authors:  Yoshiaki Okada; Haruaki Nobori; Mikiko Shimizu; Miho Watanabe; Masaaki Yonekura; Tomoko Nakai; Yuko Kamikawa; Atsuko Wakimura; Nobuaki Funahashi; Hiroki Naruse; Ayako Watanabe; Daisuke Yamasaki; So-ichiro Fukada; Kazuta Yasui; Kayoko Matsumoto; Takahiro Sato; Kenji Kitajima; Toru Nakano; William C Aird; Takefumi Doi
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

9.  Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion.

Authors:  Ingmar Bruns; Daniel Lucas; Sandra Pinho; Jalal Ahmed; Michele P Lambert; Yuya Kunisaki; Christoph Scheiermann; Lauren Schiff; Mortimer Poncz; Aviv Bergman; Paul S Frenette
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

10.  Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F.

Authors:  Pontus Lundberg; Hitoshi Takizawa; Lucia Kubovcakova; Guoji Guo; Hui Hao-Shen; Stephan Dirnhofer; Stuart H Orkin; Markus G Manz; Radek C Skoda
Journal:  J Exp Med       Date:  2014-10-06       Impact factor: 14.307
View more
  1 in total

1.  Proteomic identification of proliferation and progression markers in human polycythemia vera stem and progenitor cells.

Authors:  Ge Tan; Witold E Wolski; Sandra Kummer; Mara Hofstetter; Alexandre P A Theocharides; Markus G Manz; Ruedi Aebersold; Fabienne Meier-Abt
Journal:  Blood Adv       Date:  2022-06-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.